Media Thread, page-17065

Hey jds1988,
There's no doubting Diamond Equity has some skin in the game when it comes to IMU.
Whilst we often refer to the share price as being undervalued and even manipulated at times, I see the IMU SP in two different aspects. The one we're at with a non revenue and non dividend Bio start up company, competing for investor dollars in some of the tightest monetary times in decades. Then I look at where it can go (either way) on the back of data or a deal, providing funding or revenue. Should solid data comprising a few more complete responses come shortly- It doesn't really matter who's previously been holding IMU shares, be it retail or institutions, as the share price will soar !

I symphysis with long term holders who simply just cant wait any longer, in seeing IMU do something. I'm not rude enough in offending them, based on their financial needs or patients in trying to retrieve what's left of their investment.
Put simply, IMU was so overvalued in 2021 (going from $0.05c to $0.63.5c) The fallout has seen a steady decline in share price (with the occasional spike based on data results) with three consecutive annual losses of at least 40% each year . We're now trading at less than 7% off that high in 2021. Those retail investors who bought in comprised over 70% of investors, caught up in all of the FOMO (fear of missing out) back then. Well the good news is that those who needed to get out, already have. The sell lists daily, are now being overshadowed with buyers. With data being held back so long, and put back twice now- be it good or bad, data is coming from all three studies.

Us long term holders, really have been patient over the past three years. Be it BOOM or BUST, the next six months will tell all.
I simply don't see how recent expansions to the studies could have happened, should the dosages and efficacy not be there in the study results. Leslie Chong and Yuman Fong have made presentations, showing their not only satisfaction- but delight, in what they're seeing. That's formed a trust, for those of us having a faith in the science. That's why I've stated Leslie needs to only rare her head once she has news, comprising data or deals. Any more repetitious promotions, not including what's been long awaited, will only further damage her reputation and the share price. We've signed off on paying her more than $2m for another year, back in November.
The capital raise only contributed $20m (no options exercised). If she's so frugal with capital, 10% of that whole company capital raise will be her wages. We really need to see less talk, coupled with data we've sat on the edge of our seats waiting for over 14 months.

I try to keep it balanced. I still see IMU as potentially the best stock amongst hundreds, I've held for over 38 years of trading. However, I'm not happy with the lack of news and company direction, shown by IMU management.

I'm more than aware and very excited, that this next six months reveals all !


-GO IMU!

Not Financial Advice - Opinions Only - DYOR!